Navigation Links
Comparative Study Shows Significant Bone In-growth and Advanced Clinical Outcomes Using Zimmer's Trabecular Metal(TM) Technology
Date:2/25/2009

10-Year Study Highlights Trabecular Metal Technology's Clinical Success Over Traditional Metal Implants

WARSAW, Ind., Feb. 25 /PRNewswire-FirstCall/ -- Zimmer Holdings, Inc. (NYSE: ZMH; SWX: ZMH), a leader in the orthopaedic industry, today announced that data from an independent 10-year Trabecular Metal(TM) Technology comparative clinical study demonstrates the osteoconductive properties of Zimmer's Trabecular Metal Technology. The study found bone-to-implant gap-filling and positive clinical outcomes up to 10 years after total hip arthroplasty (THA) using products made with Zimmer's Trabecular Metal Technology.

"This study reaffirms the positive clinical outcomes associated with using Trabecular Metal technology," commented Cheryl Blanchard, PhD, Zimmer's Senior Vice President, Research and Development, and Chief Scientific Officer. "Unique to Zimmer, Trabecular Metal technology allows for highly porous metal implants with flexibility very similar to cancellous bone."

The study, to be published in the Journal of Arthroplasty, followed 143 patients for up to 10 years post-THA. Findings indicate that Trabecular Metal monoblock implants result in a marked reduction in metallic and polyethylene debris and maximize the area available for bone in-growth. Further, the researchers observed a zero revision rate for aseptic loosening throughout the duration of the study and no incidence of implant migration and no radiographic evidence of gross polyethylene wear as measured digitally with (EBRA) Ein-Bild-Rontgen-Analyse.

"It is important to note that this study addresses concerns that have not been previously well characterized. It provides invaluable information about these mid-term outcomes after total hip arthroplasty and the potential adva
'/>"/>

SOURCE Zimmer Holdings, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. MAP Pharmaceuticals Reports Positive Results From Comparative Pharmacokinetic Trial for its Pediatric Asthma Product Candidate
2. New Study Confirms That the Supports Intensity Scale Assessment is Effective in Measuring the Support Needs of People With Intellectual Disability and Making Funding Decisions
3. Childrens Hospital Receives $6.7 Million Grant From Gates Foundation to Study Influenza Vaccine in Pregnant Women in Asia
4. MAP Pharmaceuticals Announces Phase 3 Study of Unit Dose Budesonide in Children With Asthma Did Not Meet Primary Endpoints
5. AstraZenecas Partner, MAP Pharmaceuticals, Announces Phase 3 Study of Unit Dose Budesonide in Children with Asthma Did Not Meet Primary Endpoints
6. Data from Phase 2 Study of Peramivir in Patients Hospitalized with Influenza Presented at the XI International Symposium on Respiratory Viral Infections
7. 10-State Project to Study Methods to Reduce Central Line-Associated Bloodstream Infections in Hospital ICUs
8. Sanofi Pasteur Dengue Vaccine Enters Pediatric Efficacy Clinical Study
9. Sanofi Pasteur Starts a Phase II Study of a Vaccine Against Clostridium Difficile
10. ViroPharma Announces Discontinuation of Maribavir Phase 3 Study in Liver Transplant Patients
11. Hope for 14 Million Rosacea Sufferers: Pyratine-XR(TM) Study to be Presented at South Beach Symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2014)... , Dec. 12, 2014 Research and Markets ... ( http://www.researchandmarkets.com/research/ms3j8c/cardiac ) has announced the addition ... and Forecasts, 2012-2018"  report to their offering. Global ... 2016. The North America accounts ... Europe claims approximately 25% (2018). ...
(Date:12/15/2014)... and BRIDGEWATER, N.J. , Dec. ... and Sanofi US (EURONEXT: SAN and NYSE: SNY) are ... to launch Cholesterol Counts , an awareness program ... their numbers, and the risks associated with high LDL-C ... www. CholesterolCounts .com to take a brief poll ...
(Date:12/15/2014)... SAN MARCOS, Texas , Dec. 15, 2014 /PRNewswire/ ... quantum dot manufacturer Quantum Materials Corp (OTCQB:QTMM), ... Rice Center for Quantum Materials (RCQM) on December 16th, ... the exploration of exotic nanomaterials in attracting top faculty ... to Rice to collaborate on research. ...
Breaking Medicine Technology:Cardiac Guidewires - Global Trends, Estimates and Forecasts, 2012-2018 2Cardiac Guidewires - Global Trends, Estimates and Forecasts, 2012-2018 3Cardiac Guidewires - Global Trends, Estimates and Forecasts, 2012-2018 4Have You Been Counted? Regeneron and Sanofi US Join Forces with Leading Cardiovascular Organizations to Raise Awareness of Cholesterol 2Have You Been Counted? Regeneron and Sanofi US Join Forces with Leading Cardiovascular Organizations to Raise Awareness of Cholesterol 3Have You Been Counted? Regeneron and Sanofi US Join Forces with Leading Cardiovascular Organizations to Raise Awareness of Cholesterol 4Have You Been Counted? Regeneron and Sanofi US Join Forces with Leading Cardiovascular Organizations to Raise Awareness of Cholesterol 5Have You Been Counted? Regeneron and Sanofi US Join Forces with Leading Cardiovascular Organizations to Raise Awareness of Cholesterol 6Quantum Materials CEO Stephen Squires to Speak at Rice Center for Quantum Materials Launch 2Quantum Materials CEO Stephen Squires to Speak at Rice Center for Quantum Materials Launch 3
(Date:12/17/2014)... HealthDay Reporter , TUESDAY, Dec. 16, 2014 (HealthDay ... work commitment is a big reason why, new research suggests. ... Mathias Basner, an assistant professor of sleep and chronobiology in ... A time-use survey of nearly 125,000 Americans, ages 15 ... exchanged for sleep. Short sleepers -- those who slept six ...
(Date:12/15/2014)... Street Dental Team ( http://www.MainStreetDentalTeam.com ), Unionville’s first full-time ... providing evidence on the impact of 100% pure fruit ... enough evidence already exists showing a negative link between ... the onset of tooth decay. One question that has ... fruit juice, meaning it is completely natural with no ...
(Date:12/15/2014)... Health Dialog, a leading provider ... it has received Patient Oriented Accreditation from the ... Disease Management (DM) Programs for asthma, congestive heart ... disease and diabetes. This marks the 12th continuous ... Disease Management (DM) Programs, reaffirming Health Dialog’s focus ...
(Date:12/15/2014)... 15, 2014 Kathy McAfee, America's Marketing ... World Awards in the category of Best Blog 2014. ... for her weekly career blog Networking Ahead ... help professionals elevate their talent and influence through better ... after her book Networking Ahead for Business, has been ...
(Date:12/15/2014)... Ontario (PRWEB) December 15, 2014 Bacteroides is ... Not only is it much more prevalent than coliforms, it ... replicate in the environment. , Key Benefits of the ... for fecal contamination , Eliminates false positives from ... Specificity and Sensitivity , Maintain the same ...
Breaking Medicine News(10 mins):Health News:Work Steals Valuable Sleep Time, Study Finds 2Health News:Work Steals Valuable Sleep Time, Study Finds 3Health News:Main Street Dental Team, Unionville’s Most Innovative Dental Clinic, Comments on New Study Relating Pure Fruit Juice to Poor Oral Hygiene 2Health News:Health Dialog Receives NCQA Accreditation for Disease Management Programs 2Health News:Kathy McAfee, America’s Marketing Motivator, Wins Best Blog from Women World Awards 2
... N.C., Feb. 5 Many leading companies have ... various reasons, but in times of economic adversity, ... functions within companies are being questioned. Although internal ... purpose, these organizations often grow and take on ...
... Republic of The Gambia has decided to create a ... (Iniciaci sense mutilaci), directed by UAB researcher Adriana Kaplan, ... Institute of Primary Care Research IDIAP Jordi Gol and ... eliminate the genital lesions created by these traditional rituals ...
... (CMC) has,selected Surgical Information Systems (SIS) to be ... in Scranton, PA. , ... CMC chose the SIS Solution ... and operational efficiencies in the surgery department.,In addition ...
... Minutes Without Side Effects or PillsPHOENIX and SCOTTSDALE, ... specialist Morton I. Hyson, M.D., will announce a ... according to Clinical Topicals PHP. The treatment works ... or contraindications ( www.HysonHeadache.com ). After a decade ...
... preventing cystic fibrosis lung disease in an animal model by ... the first therapy to successfully attack the root cause of ... mice are given inhalation treatment with the drug in the ... lungs and airway inflammation and chronic lung damage can be ...
... Barcode Point-of-Care Patient Safety Solution-SAN DIEGO, Feb. 5 ... barcode point-of-care (BPOC) solutions to hospitals, today announced ... is now being used by 55 U.S. hospitals. ... to go live with the IntelliDOT System on January ...
Cached Medicine News:Health News:New Study Provides Benchmarks for Best Practices for Valuing Internal Consulting Organizations 2Health News:Gambia takes on as National Program UAB project to abolish FGM 2Health News:Gambia takes on as National Program UAB project to abolish FGM 3Health News:Community Medical Center (Scranton) Selects SIS Perioperative Solution 2Health News:Neurologist to Announce Breakthrough Headache Treatment 2Health News:Hope for preventative treatment for cystic fibrosis lung disease 2Health News:Hope for preventative treatment for cystic fibrosis lung disease 3Health News:IntelliDOT Bedside Medication Administration(TM) Goes Live at 55th Hospital 2Health News:IntelliDOT Bedside Medication Administration(TM) Goes Live at 55th Hospital 3Health News:IntelliDOT Bedside Medication Administration(TM) Goes Live at 55th Hospital 4
... model CC4204BF, is a single ... the capsular bag. The lens ... post-operative fixation. The light patterns ... are nearly identical to those ...
The STAAR ELASTIMIDE™ lens, combines the best of foldable lens technology with traditional design. This lens contains a cast-molded, silicone optic with modified Polyimide haptics....
... at Pfizer used wavefront sensing to invent ... Innovative TECNIS features a patented modified prolate ... which compensates for the positive spherical aberration ... is the first and only IOL with ...
Multi piece lens, AC depth: 4.2....
Medicine Products: